DexCom
DXCM
$107.71
Share price
0.58%
Change (1 day)
-75.24%
Change (1 year)
Categories
Market capitalization of DexCom (DXCM)
Market cap: $42.27 Billion
As of February 2023 DexCom has a market cap of $42.27 Billion. This makes DexCom the world's 421th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of DexCom from 2005 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $42.27 B | -4.88% |
| 2022 | $44.44 B | -14.6% |
| 2021 | $52.04 B | 46.58% |
| 2020 | $35.50 B | 77.19% |
| 2019 | $20.03 B | 85.83% |
| 2018 | $10.78 B | 116.19% |
| 2017 | $4.98 B | -1.16% |
| 2016 | $5.04 B | -24.59% |
| 2015 | $6.69 B | 57.24% |
| 2014 | $4.25 B | 65.76% |
| 2013 | $2.56 B | 171.81% |
| 2012 | $0.94 B | 50.27% |
| 2011 | $0.62 B | -25.83% |
| 2010 | $0.84 B | 128.04% |
| 2009 | $0.37 B | 351.42% |
| 2008 | $82.31 M | -67.43% |
| 2007 | $0.25 B | 1.78% |
| 2006 | $0.24 B | -33.91% |
| 2005 | $0.37 B |
End of Day market cap according to different sources
On Feb 1st, 2023 the market cap of DexCom was reported to be:
$41.60 Billion
$42.27 Billion
$41.60 Billion
$41.59 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $431.18 B | 919.91% | 🇺🇸 USA |
 Abbott Laboratories ABT | $194.96 B | 361.17% | 🇺🇸 USA |
 Medtronic MDT | $114.08 B | 169.87% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $72.25 B | 70.91% | 🇺🇸 USA |
 Edwards Lifesciences EW | $50.37 B | 19.16% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $2.66 B | -93.70% | 🇺🇸 USA |
 QuidelOrtho QDEL | $5.84 B | -86.17% | 🇺🇸 USA |
 West Pharmaceutical WST | $20.10 B | -52.44% | 🇺🇸 USA |